Goldman Sachs
AMPE

Goldman Sachs’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Goldman Sachs’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-646
Closed -$3.01K – 6300
2023
Q1 		$3.01K Buy
+646
New +$3.63K ﹤0.01% 5834
2022
Q4 		– Sell
-159
Closed -$3K – 6649
2022
Q3 		$3K Sell
159
-59
-27% -$2.07K ﹤0.01% 6165
2022
Q2 		$11K Buy
218
+20
+10% +$1.49K ﹤0.01% 6265
2022
Q1 		$28K Sell
198
-485
-71% -$70.8K ﹤0.01% 6372
2021
Q4 		$118K Buy
683
+240
+54% +$89.5K ﹤0.01% 6090
2021
Q3 		$220K Sell
443
-211
-32% -$97.8K ﹤0.01% 5683
2021
Q2 		$327K Sell
654
-416
-39% -$223K ﹤0.01% 5471
2021
Q1 		$542K Buy
1,070
+1,029
+2,510% +$531K ﹤0.01% 5057
2020
Q4 		$19K Buy
+41
New +$13.4K ﹤0.01% 5439
2019
Q3 		– Sell
-1,648
Closed -$191K – 5460
2019
Q2 		$191K Buy
1,648
+1,484
+905% +$235K ﹤0.01% 4806
2019
Q1 		$27K Sell
164
-92
-36% -$15.8K ﹤0.01% 5034
2018
Q4 		$31K Sell
256
-18
-7% -$2.76K ﹤0.01% 5127
2018
Q3 		$42K Buy
274
+203
+286% +$84.9K ﹤0.01% 5321
2018
Q2 		$47K Sell
71
-861
-92% -$644K ﹤0.01% 5366
2018
Q1 		$950K Buy
+932
New +$780K ﹤0.01% 4083
2017
Q3 		– Sell
-945
Closed -$148K – 6943
2017
Q2 		$148K Buy
945
+876
+1,270% +$177K ﹤0.01% 5957
2017
Q1 		$17K Buy
+69
New +$18.5K ﹤0.01% 6552
2016
Q4 		– Sell
-42
Closed -$9K – 7158
2016
Q3 		$9K Buy
42
+6
+17% +$1.68K ﹤0.01% 6889
2016
Q2 		$14K Buy
+36
New +$39.3K ﹤0.01% 6805
2016
Q1 		– Sell
-76
Closed -$80K – 7397
2015
Q4 		$80K Sell
76
-298
-80% -$295K ﹤0.01% 6296
2015
Q3 		$325K Sell
374
-232
-38% -$194K ﹤0.01% 5536
2015
Q2 		$431K Buy
606
+359
+145% +$383K ﹤0.01% 5342
2015
Q1 		$558K Buy
247
+67
+37% +$114K ﹤0.01% 5018
2014
Q4 		$186K Buy
+180
New +$192K ﹤0.01% 6212
2014
Q2 		– Sell
-124
Closed -$237K – 7193
2014
Q1 		$237K Sell
124
-9
-7% -$21.3K ﹤0.01% 5933
2013
Q4 		$283K Sell
133
-154
-54% -$364K ﹤0.01% 5736
2013
Q3 		$646K Buy
287
+15
+6% +$29K ﹤0.01% 4957
2013
Q2 		$470K Buy
+272
New +$432K ﹤0.01% 4991

Other funds holding AMPE

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Goldman Sachs's AMPE Position: Q2 2023 in Review

Goldman Sachs sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2023, closing a stake of 646 shares — an estimated $3.01K sold.

Goldman Sachs first reported a position in AMPE in Q2 2013 and held it in 28 quarters. The position peaked at $950K in Q1 2018. 34 funds tracked by Wall St. Rank hold AMPE as of Q2 2023.

  • Goldman Sachs reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2023 after selling out during the quarter.
  • Goldman Sachs sold 646 Ampio Pharmaceuticals Inc. shares in Q2 2023, an estimated $3.01K.
  • Goldman Sachs first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 28 quarters.
  • Goldman Sachs's Ampio Pharmaceuticals Inc. position peaked at $950K in Q1 2018.
  • 34 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.